GlassScriptPhysician profile
Carmen Stanko
NPI 1417062886
$1,567.89
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $324 · 2021: $152 · 2022: $193 · 2023: $8.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $277.02 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $254.64 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $224.20 | 2019 | |
| Travere Therapeutics, INC. | $169.35 | 2019-2023 | |
| Amgen INC. | $129.09 | 2019-2021 | |
| Amicus Therapeutics, INC. | $113.52 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $71.97 | 2019 | |
| Mallinckrodt Hospital Products INC. | $65.02 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $47.42 | 2019-2021 | |
| Horizon Therapeutics Plc | $45.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $44.43 | 2019 | |
| Glaxosmithkline, LLC. | $35.04 | 2019-2020 | |
| Akebia Therapeutics INC | $34.97 | 2020 | |
| Nxstage Medical, INC. | $21.68 | 2019 | |
| Daiichi Sankyo INC. | $17.93 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.46 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Stanko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.